1.
INVESTIGATIONS ON CLINICAL VALIDATION OF MUTATED ZNF208 AS A NOVEL BIOMARKER OF BLAST CRISIS IN CHRONIC MYELOID LEUKEMIA. J Popl Ther Clin Pharmacol. 2024;31(9):1502-1518. doi:10.53555/68zhqm37